Heart Team 2.0

EuroIntervention 2019;15:825-827. DOI: 10.4244/EIJV15I10A155

Michael Reardon
Michael J. Reardon1, MD; Martin B. Leon2, MD; Jeffrey J. Popma3, MD; Michael J. Mack4, MD
1. Houston Methodist Hospital, Houston, TX, USA; 2. NewYork-Presbyterian Columbia University Medical Center, New York, NY, USA; 3. Beth Israel Deaconess Medical Center, Boston, MA, USA; 4. Baylor Scott & White Heart Hospital Plano, Plano, TX, USA

The management of all diseases can range from the simple to the very complex. This holds true for cardiovascular diseases with a tendency to favour the complex end of the spectrum. The concept of treating complex disease with the input of a multidisciplinary team is not new. The care and management of malignant diseases and organ transplantation has long used such multidisciplinary teams to achieve appropriate diagnosis, treatment planning and execution. In the cardiovascular world this was highlighted by the use of Heart Teams in the SYNTAX trial and the benefit seen from this approach1. In both the oncology ...

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
Eyes of the Heart Team – the interventional imaging specialist: a pathway for future generations

Latest news